[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to Be Registered Amount to Be (1) Proposed Maximum Amount of (2) Share of Common Stock, $.001 par value 1,610,000 17,710,000 988.22 (3) (4) Representative’s Common Stock Purchase Option] [UNDERWRITING AGREEMENT between SKYSTAR BIO-PHARMACEUTICAL COMPANY and RODMAN & RENSHAW, LLC as Representative SKYSTAR BIO-PHARMACEUTICAL COMPANY UNDERWRITING AGREEMENT New York, New York ___________ __, 2009 Rodman & Renshaw, LLC th 1251 Avenue of the Americas, 20 New York, New York 10020 Ladies and Gentlemen: Company you Representative Underwriters Underwriter Purchase and Sale of Securities 1. Firm Securities 1.1. Nature and] [EX-4.1 11 v153379_ex4-1.htm] [THE REGISTERED HOLDER OF THIS PURCHASE OPTION BY ITS ACCEPTANCE HEREOF, AGREES THAT IT WILL NOT SELL, TRANSFER OR ASSIGN THIS PURCHASE OPTION EXCEPT AS HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE OPTION AGREES THAT IT WILL NOT SELL, TRANSFER, ASSIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE OPTION FOR A PERIOD OF ONE HUNDRED EIGHTY DAYS FOLLOWING THE EFFECTIVE] [RICHARDSON & PATEL LLP 10900 Wilshire Boulevard Suite 500 Los Angeles, California 90024 Telephone (310) 208-1183 Facsimile (310) 208-1154 June 26, 2009 SKYSTAR BIO-PHARMACEUTICAL COMPANY Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xi’an, Shaanxi Province, P.R. China Re: SKYSTAR BIO-PHARMACEUTICAL COMPANY Registration Statement on Form S-1 Ladies and Gentlemen: We do not find it necessary for the] [Consent of Independent Registered Public Accounting Firm Skystar Bio-Pharmaceutical Company and Subsidiaries Audited Financial Statements December 31, 2008 and 2007 To The Board of Directors Skystar Bio-Pharmaceutical Company Walnut, California June 26, 2009 EX-23.1 15 v153379_ex23-1.htm] [Response: Under applicable PRC law, payment of registered capital is satisfied by a bank confirmation of the required amount in the bank account of the FIE and a registered capital verification report issued by a local accounting firm. Once both conditions are satisfied, the money is not required to be preserved in the FIE’s bank account. Thus, while $3 million]

[CALCULATION OF REGISTRATION FEE Title of Each Class of Securities to Be Registered Amount to Be (1) Proposed Maximum Amount of (2) Share ofmmon Stock, $.001 par value 1,610,000 17,710,000 988.22 (3) (4) Representativesmmon Stock Purchase Option 1 Option 100 Shares ofmmon Stock underlying Representativesmmon Stock Purchase Option] [UNDERWRITINGREEMENT betweenYSTAR BIO-PHARMACEUTICALMPANY and RODMAN & RENSHAW, RepresentativeYSTAR BIO-PHARMACEUTICALMPANY UNDERWRITINGREEMENT New York, New York ___________ __, 2009 Rodman & Renshaw, th 1251 Avenue of the Americas, 20 New York, New York 10020 Ladies and Gentlemen:mpany you Representative Underwriters Underwriter Purchase andle of Securities] [v153379_ex4-1.htm 11 EX-4.1] [THE REGISTERED HOLDER OF THIS PURCHASE OPTION BY ITS ACCEPTANCE HEREOF,REES THAT IT WILL NOT SELL, TRANSFER ORSIGN THIS PURCHASE OPTION EXCEPT HEREIN PROVIDED AND THE REGISTERED HOLDER OF THIS PURCHASE OPTIONREES THAT IT WILL NOT SELL, TRANSFER,SIGN, PLEDGE OR HYPOTHECATE THIS PURCHASE OPTION FOR A PERIOD OF ONE HUNDRED EIGHTYYS FOLLOWING THE EFFECTIVETE (DEFINED] [RICHARDSON & PATEL 10900 Wilshire Boulevard Suite 500 Los Angeles,lifornia 90024 Telephone (310) 208-1183 Facsimile (310) 208-1154 June 26, 2009YSTAR BIO-PHARMACEUTICALMPANY Rm. 10601, Jiezuo Plaza, No.4, Fenghui Road South, Gaoxin District, Xian, Shaanxi Province, P.R. China Re:YSTAR BIO-PHARMACEUTICALMPANY Registration Statement on Form S-1 Ladies and Gentlemen:] [Consent of Independent Registered Public Accounting Firmystar Bio-Pharmaceuticalmpany and Subsidiaries Audited Financial Statements December 31, 2008 and 2007 To The Board of Directorsystar Bio-Pharmaceuticalmpany Walnut,lifornia June 26, 2009 v153379_ex23-1.htm 15 EX-23.1] [Richardson & Patel 10900 Wilshire Boulevard, Suite 500 Los Angeles,lifornia 90024 Tel: (310) 208-1182 Fax: (310) 208-1154 June 26, 2009 FILED EDGARRRESPONDENCE & VIA FEDERAL EXPRESS Division ofrporation Finance 100 F. Street, N.E. Attn: Jennifer Riegel Re:ystar Bio-Pharmaceuticalmpany Registration Statement on Form S-1/A Filed June 2, 2008]